Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Five Prime Therapeutics, Inc. (FPRX)

« Back to company index

FPRX Chatter Timeline

Stock Ticker for FPRX

Most Active Tweeters for FPRX

No tweets found

Recent Tweets for FPRX

EnterpriseLeade @EnterpriseLeade
Five Prime Therapeutics $FPRX Downgraded to Strong Sell at ValuEngine https://t.co/8s5otQl8UP
August 21st 2018, 11:08pm
InsiderAlertsIA @InsiderAlertsIA
$FPRX: New Insider Filing on President & CEO ARON MARC KNICKERBOCKER: https://t.co/sFZ6ox8zYg
August 21st 2018, 5:08pm
LargeVoidBot @LargeVoidBot
Daily Reversal (13:26): $FPRX Last: 13.39; pHigh: 13.38; rVol: 1.034; pClose: 13.30; LOD: 12.9100; Perf: 0.7%
August 21st 2018, 5:08pm
StockTexts @StockTexts
$FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 4 https://t.co/Ikw1J5uDvU
August 21st 2018, 4:08pm
ZolmaxNews @ZolmaxNews
Five Prime Therapeutics $FPRX Price Target Cut to $44.00 by Analysts at Citigroup https://t.co/abdPrNUX3c
August 21st 2018, 9:08am
dakotafinancial @dakotafinancial
Five Prime Therapeutics $FPRX Reaches New 12-Month Low Following Analyst Downgrade https://t.co/b2xkp2ot0G
August 21st 2018, 5:08am
TheMarketsDaily @TheMarketsDaily
Five Prime Therapeutics $FPRX Hits New 12-Month Low on Analyst Downgrade https://t.co/2CW6iJZaEa
August 20th 2018, 5:08pm
AmericanBanking @AmericanBanking
Five Prime Therapeutics $FPRX Given New $44.00 Price Target at Citigroup https://t.co/XZ9r1EtWBP #stocks
August 20th 2018, 3:08pm
Emylers @Emylers
FPRX Stock 13.25 Five Prime Thera $FPRX Hit 288,685 52 week lows as of +4.50%. Currently trading at 13.25 +0.0 https://t.co/0suAVNwDY8
August 20th 2018, 2:08pm
dakotafinancial @dakotafinancial
Citigroup Trims Five Prime Therapeutics $FPRX Target Price to $44.00 https://t.co/jP2zo9h5XI
August 20th 2018, 2:08pm
macondailynews @macondailynews
Citigroup Trims Five Prime Therapeutics $FPRX Target Price to $44.00 https://t.co/SN2YzOfNI3
August 20th 2018, 2:08pm
tgtxdough @tgtxdough
Citi $FPRX conservative,stripped out PVNS study from pipeline, which results in a ~$7/sh cut to our DCF.cabiralizum… https://t.co/fhZ3kwZbnR
August 20th 2018, 1:08pm
The_CasualSmart @The_CasualSmart
Trillium Asset Management Has Lifted By $343,740 Its Five Prime Therapeutics $FPRX Holding; 10 Analysts Bullish Hal… https://t.co/sf1GOINN4P
August 20th 2018, 12:08pm
bibeypost_stock @bibeypost_stock
Five Prime Therapeutics $FPRX "Buy" Rating Reiterated Today By Citigroup; The PT Given is $44 - https://t.co/84LyEOCxeY
August 20th 2018, 11:08am
reurope_stock @reurope_stock
Today Citigroup Reconfirms a "Buy" Rating on Five Prime Therapeutics $FPRX and a $44 Target Price https://t.co/RhA8MKSgBa
August 20th 2018, 11:08am
mmahotstuff1 @mmahotstuff1
Citigroup Reconfirms Five Prime Therapeutics $FPRX As a Buy; They Now Have a TP Of $44 - https://t.co/5zWQVZlVO5
August 20th 2018, 11:08am
The_CasualSmart @The_CasualSmart
Citigroup Has Just Reaffirmed $44 Target Price Per Share on Five Prime Therapeutics $FPRX stock, While They’ve Also… https://t.co/PhABpus4F1
August 20th 2018, 11:08am
whatsonthorold2 @whatsonthorold2
Analysts at Citigroup Reiterated their Past ‘Buy’ rating on Shares Five Prime Therapeutics $FPRX, Set a $44 Price T… https://t.co/aymo2Ix7nP
August 20th 2018, 11:08am
west_moreland @west_moreland
Key Analysts at Citigroup Kept their ‘"Buy"’ rating for Five Prime Therapeutics $FPRX Shares Today. Their Target Pr… https://t.co/f8kGpbJQse
August 20th 2018, 11:08am
The_CasualSmart @The_CasualSmart
Today Citigroup Keeps a Buy Rating on Five Prime Therapeutics $FPRX and a $44 Target Price https://t.co/8vK0R7IYrx
August 20th 2018, 11:08am
Fanob_stock @Fanob_stock
Breaking: Five Prime Therapeutics $FPRX Buy Rating Reaffirmed at Citigroup Today; The Target Given is $44 https://t.co/EqwEp8zyL9
August 20th 2018, 11:08am
Luigimoro69 @Luigimoro69
@stb8444 $FPRX Have been investing long in biotechs? this was over 40 last October and will go there again. Shortse… https://t.co/UfHRdqWSRF
August 20th 2018, 10:08am
stb8444 @stb8444
$fprx someone is getting steamrolled here $12
August 20th 2018, 9:08am
odibro @odibro
$FPRX maintained with a buy at CITI. PT $44
August 20th 2018, 7:08am
laang15 @laang15
Binance registration is currently open Register link and BONUS ? https://t.co/mTmCbzBn3W ? 08/20 04:03 $FPRX $GDO… https://t.co/mltc1ZVXLy
August 20th 2018, 4:08am
Luigimoro69 @Luigimoro69
@BenjiMax2 @DrSManian $FPRX about 250m cash by end of the year unbelievable cheap IMO and a big pipeline and trials… https://t.co/BtUAza2Xdi
August 19th 2018, 5:08pm
sunrgu @sunrgu
@DrSManian Standout $FPRX and may be $SYBX
August 19th 2018, 3:08pm
MareaInformativ @MareaInformativ
Wedbush Boosts Five Prime Therapeutics $FPRX Price Target to $19.00 https://t.co/77yEfv7OIb
August 19th 2018, 11:08am
beyond_ninety @beyond_ninety
Kdi Capital Partners Trimmed Lawson Prods $LAWS Holding; Five Prime Therapeutics, Inc. $FPRX Had 3 Bulls https://t.co/lm0jwcsZy2
August 19th 2018, 9:08am
ZolmaxNews @ZolmaxNews
Five Prime Therapeutics $FPRX Downgraded by BidaskClub https://t.co/i0UBpCq0kU
August 19th 2018, 4:08am
TickerReport @TickerReport
-$1.16 EPS Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/DAPjIkf6F6
August 18th 2018, 11:08pm
WatchlistN @WatchlistN
-$1.16 EPS Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/j7x9rfvkHP
August 18th 2018, 11:08pm
MareaInformativ @MareaInformativ
Zacks: Analysts Anticipate Five Prime Therapeutics Inc $FPRX Will Post Earnings of -$1.31 Per Share https://t.co/3HeOPbmjdO
August 18th 2018, 4:08pm
TickerReport @TickerReport
Five Prime Therapeutics $FPRX Downgraded by BidaskClub https://t.co/TvRzLvO1g5
August 18th 2018, 11:08am
dailypoliticaln @dailypoliticaln
Five Prime Therapeutics $FPRX Downgraded to “Sell” at BidaskClub https://t.co/d3PYbRUDvT
August 18th 2018, 11:08am
EnterpriseLeade @EnterpriseLeade
Five Prime Therapeutics $FPRX Price Target Cut to $35.00 https://t.co/u5BYqtZIDJ
August 18th 2018, 8:08am
1MinuteStock @1MinuteStock
Unicorn Bay rating for $FPRX is 1.69 out of 5. https://t.co/eVCNHf0hLb
August 18th 2018, 7:08am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $FPRX? The Short Ratio is 8.12% https://t.co/0mPOVO3pb3
August 18th 2018, 6:08am
TheUnicornBay @TheUnicornBay
Btw, Estimated #Earnings Per Share for $FPRX is $-1.31 it's -9.94% of the current price https://t.co/IsGEOR5nmC
August 18th 2018, 6:08am
1MinuteStock @1MinuteStock
Do you know that #Book Value for $FPRX is $10.55 https://t.co/GzXsjhiBfQ
August 18th 2018, 5:08am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $FPRX is $-1.31 it's -9.94% of the current price https://t.co/DX86jWrkOj
August 18th 2018, 4:08am
MareaInformativ @MareaInformativ
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Five Prime Therapeutics $FPRX Stock Price https://t.co/qmedLOMaIv
August 17th 2018, 6:08pm
WeekHerald @WeekHerald
Five Prime Therapeutics $FPRX Downgraded by BidaskClub https://t.co/7nWTZ2DUiG
August 17th 2018, 5:08pm
OlympiaReport @OlympiaReport
BidaskClub Downgrades Five Prime Therapeutics $FPRX to Sell https://t.co/0LzMubD3XX
August 17th 2018, 5:08pm
Luigimoro69 @Luigimoro69
$FPRX bought another 800shares at 13.48$ now. I think it will double within 12 months. cash ?250m by end of the y… https://t.co/6m8Fyq7qSG
August 17th 2018, 10:08am
registrarjourn @registrarjourn
Brokerages Anticipate Five Prime Therapeutics Inc $FPRX Will Announce Earnings of -$1.25 Per Share https://t.co/RVmmZFHII0
August 17th 2018, 2:08am
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Anticipate Five Prime Therapeutics Inc $FPRX Will Announce Quarterly Sales of $7.45 Million https://t.co/8V1ZHxZQQv
August 16th 2018, 4:08pm
OlympiaReport @OlympiaReport
-$1.16 EPS Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/ay3N2GhhCn
August 16th 2018, 4:08pm
WeekHerald @WeekHerald
Analysts Anticipate Five Prime Therapeutics Inc $FPRX Will Announce Quarterly Sales of $7.45 Million https://t.co/AKqtLgxbUH
August 16th 2018, 4:08pm
dispatchtribune @dispatchtribune
Analysts Anticipate Five Prime Therapeutics Inc $FPRX to Announce -$1.16 Earnings Per Share https://t.co/LhpagBQIpz
August 16th 2018, 4:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.